Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 17,726 shares at $17.97 ($319K) on 2019-11-18, disclosed to the SEC on 2019-11-20.
Seasonal sale ($319k) by SVP, COO & CFO — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.97 | 8,863 | $159K | 50.0% |
| 2 | $17.97 | 8,863 | $159K | 50.0% |
| Total | $17.97 avg | 17,726 | $319K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |